Withdrawal of Azathioprine in Inflammatory Bowel Disease Patients Who Sustain Remission: New Risk Factors for Relapse

MLA

Julia Herreras, et al. Withdrawal of Azathioprine in Inflammatory Bowel Disease Patients Who Sustain Remission: New Risk Factors for Relapse. Jan. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b4b0e110ffbc1e49ba88589c5855a91e&authtype=sso&custid=ns315887.

APA

Julia Herreras, Marta Maia Bosca-Watts, Elena Cerrillo, Galo A. Trejo, Marisa Iborra, David Hervás, Xavier Cortés, Miguel Minguez, Belén Beltrán, & Pilar Nos. (2019). Withdrawal of Azathioprine in Inflammatory Bowel Disease Patients Who Sustain Remission: New Risk Factors for Relapse.

Chicago

Julia Herreras, Marta Maia Bosca-Watts, Elena Cerrillo, Galo A. Trejo, Marisa Iborra, David Hervás, Xavier Cortés, Miguel Minguez, Belén Beltrán, and Pilar Nos. 2019. “Withdrawal of Azathioprine in Inflammatory Bowel Disease Patients Who Sustain Remission: New Risk Factors for Relapse,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b4b0e110ffbc1e49ba88589c5855a91e&authtype=sso&custid=ns315887.